The Cancer of the Pancreas Screening-5 CAPS5)Study
NCT02000089
This study is recruiting at 9 US sites in 7 states, according to its ClinicalTrials.gov record last updated .
Summary
Johns Hopkins clinical research office quality assurance group will monitor and audit this study at Johns Hopkins. The Sub Investigator at each site will be responsible for internal monitoring at their site.
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- Pancreas Cancer
- Peutz-Jeghers Syndrome (PJS)
- Gene Mutation
- Germline Mutation Carrier
- Lynch Syndrome
Eligibility basics and study details
- Study type
- Interventional
- Phase
- Phase 3
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Sponsor
- Johns Hopkins University
- Last updated on ClinicalTrials.gov
- October 9, 2025
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
Connecticut · 1
- Yale University · New Haven, CT
Maryland · 1
- Johns Hopkins Hospital · Baltimore, MD
Massachusetts · 1
- Dana Farber Cancer Center, Harvard University · Boston, MA
Michigan · 1
- University of Michigan · Ann Arbor, MI
New York · 2
- Columbia University Medical Center · New York, NY
- NYU Langone Medical Center · New York, NY
Ohio · 1
- Case Comprehensive Cancer Center, Case Western Medical Reserve · Cleveland, OH
Pennsylvania · 2
- University of Pennsylvania · Philadelphia, PA
- University of Pittsburgh · Pittsburgh, PA
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.